Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Multiple Sclerosis | 5 | 2024 | 390 | 2.410 |
Why?
|
| Gene Regulatory Networks | 4 | 2025 | 380 | 0.920 |
Why?
|
| Genome-Wide Association Study | 12 | 2025 | 1842 | 0.850 |
Why?
|
| Leukotriene Antagonists | 1 | 2024 | 16 | 0.850 |
Why?
|
| Sulfides | 1 | 2024 | 28 | 0.840 |
Why?
|
| Cyclopropanes | 1 | 2024 | 75 | 0.820 |
Why?
|
| Acetates | 1 | 2024 | 83 | 0.820 |
Why?
|
| Quinolines | 1 | 2024 | 120 | 0.780 |
Why?
|
| Pharmaceutical Preparations | 1 | 2021 | 81 | 0.660 |
Why?
|
| Epigenesis, Genetic | 2 | 2025 | 749 | 0.570 |
Why?
|
| Computational Biology | 2 | 2021 | 872 | 0.560 |
Why?
|
| Quantitative Trait Loci | 4 | 2023 | 307 | 0.530 |
Why?
|
| Quantitative Trait, Heritable | 3 | 2021 | 106 | 0.490 |
Why?
|
| Biomarkers | 3 | 2026 | 3405 | 0.440 |
Why?
|
| Gene Expression Regulation | 4 | 2025 | 2357 | 0.430 |
Why?
|
| Gene Expression Profiling | 5 | 2025 | 1833 | 0.380 |
Why?
|
| Alzheimer Disease | 3 | 2025 | 875 | 0.360 |
Why?
|
| Epigenomics | 2 | 2025 | 186 | 0.360 |
Why?
|
| Multifactorial Inheritance | 3 | 2022 | 173 | 0.330 |
Why?
|
| Brain | 5 | 2025 | 3239 | 0.290 |
Why?
|
| Transcriptome | 3 | 2025 | 1163 | 0.280 |
Why?
|
| Databases, Genetic | 2 | 2021 | 500 | 0.270 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2023 | 2862 | 0.250 |
Why?
|
| Administrative Claims, Healthcare | 1 | 2024 | 16 | 0.210 |
Why?
|
| Proteomics | 2 | 2026 | 607 | 0.210 |
Why?
|
| Sjogren's Syndrome | 1 | 2025 | 108 | 0.200 |
Why?
|
| Organ Specificity | 5 | 2022 | 400 | 0.200 |
Why?
|
| Coronary Disease | 1 | 2026 | 638 | 0.180 |
Why?
|
| Recurrence | 1 | 2024 | 1483 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2025 | 1086 | 0.160 |
Why?
|
| Software | 2 | 2022 | 752 | 0.160 |
Why?
|
| Humans | 17 | 2026 | 131680 | 0.150 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2026 | 651 | 0.150 |
Why?
|
| Cognitive Dysfunction | 1 | 2024 | 354 | 0.150 |
Why?
|
| Brain Diseases | 1 | 2021 | 305 | 0.140 |
Why?
|
| Single-Cell Analysis | 1 | 2022 | 368 | 0.140 |
Why?
|
| Models, Genetic | 1 | 2021 | 752 | 0.140 |
Why?
|
| Lung | 1 | 2026 | 1565 | 0.140 |
Why?
|
| RNA-Binding Proteins | 1 | 2021 | 550 | 0.130 |
Why?
|
| Case-Control Studies | 1 | 2024 | 3454 | 0.130 |
Why?
|
| Membrane Proteins | 1 | 2021 | 1613 | 0.100 |
Why?
|
| Cardiovascular Diseases | 1 | 2026 | 2082 | 0.100 |
Why?
|
| Heart Failure | 1 | 2026 | 2307 | 0.090 |
Why?
|
| Aged | 3 | 2026 | 21261 | 0.090 |
Why?
|
| Gene Ontology | 2 | 2021 | 53 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4952 | 0.080 |
Why?
|
| Bayes Theorem | 2 | 2022 | 306 | 0.080 |
Why?
|
| Young Adult | 1 | 2024 | 10104 | 0.080 |
Why?
|
| Linkage Disequilibrium | 2 | 2021 | 318 | 0.080 |
Why?
|
| Internet | 2 | 2022 | 422 | 0.070 |
Why?
|
| Middle Aged | 2 | 2026 | 28889 | 0.070 |
Why?
|
| Genetic Predisposition to Disease | 3 | 2025 | 3413 | 0.070 |
Why?
|
| Vital Capacity | 1 | 2026 | 89 | 0.060 |
Why?
|
| Entorhinal Cortex | 1 | 2025 | 23 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17667 | 0.060 |
Why?
|
| Adolescent | 1 | 2024 | 20982 | 0.060 |
Why?
|
| Forced Expiratory Volume | 1 | 2026 | 176 | 0.060 |
Why?
|
| Male | 3 | 2026 | 65267 | 0.050 |
Why?
|
| Transcription Factors | 2 | 2025 | 2437 | 0.050 |
Why?
|
| Female | 3 | 2026 | 71186 | 0.050 |
Why?
|
| Adult | 1 | 2024 | 31719 | 0.050 |
Why?
|
| Drugs, Investigational | 1 | 2022 | 27 | 0.050 |
Why?
|
| Causality | 1 | 2021 | 91 | 0.040 |
Why?
|
| Histone Code | 1 | 2021 | 47 | 0.040 |
Why?
|
| Datasets as Topic | 1 | 2021 | 102 | 0.040 |
Why?
|
| Hippocampus | 1 | 2025 | 806 | 0.040 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2021 | 233 | 0.040 |
Why?
|
| Metabolome | 1 | 2023 | 329 | 0.040 |
Why?
|
| Molecular Sequence Annotation | 1 | 2021 | 152 | 0.040 |
Why?
|
| Web Browser | 1 | 2020 | 7 | 0.040 |
Why?
|
| Neuroimaging | 1 | 2024 | 404 | 0.040 |
Why?
|
| Software Design | 1 | 2020 | 22 | 0.040 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 283 | 0.040 |
Why?
|
| Sequence Analysis, RNA | 1 | 2022 | 420 | 0.040 |
Why?
|
| Europe | 1 | 2020 | 372 | 0.040 |
Why?
|
| Gene Frequency | 1 | 2020 | 750 | 0.040 |
Why?
|
| Incidence | 1 | 2026 | 3347 | 0.030 |
Why?
|
| Binding Sites | 1 | 2021 | 1202 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2026 | 3834 | 0.030 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2021 | 464 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2026 | 3695 | 0.030 |
Why?
|
| Algorithms | 1 | 2022 | 1686 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2026 | 6494 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2024 | 3917 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4516 | 0.020 |
Why?
|
| Risk Factors | 1 | 2026 | 10959 | 0.020 |
Why?
|
| United States | 1 | 2026 | 11804 | 0.020 |
Why?
|